The stent hadn’t helped after all; the impacted kidney had, in fact, been irreversibly damaged and was now functioning at a ...

Boston Scientific has shown high revenue and EPS growth rates in recent years. See why I recommend a hold rating for BSX ...

Shenni Holdings plans a $15M IPO to expand in third-party medical devices. Learn about their growth, risks, and valuation before investing.

Early hepatic encephalopathy following transjugular intrahepatic portosystemic shunt (TIPS) insertion, especially within the first 30 days, was associated with reduced survival in patients with ...

Feb. 3, 2025 — The incidence of advanced prostate cancer in California rose markedly in the decade since doctors stopped routinely screening all men for the disease, according to a new ..

DelveInsight's "CABLIVI Market Size, Forecast, and Market Insight Report" highlights the details around CABLIVI, a von Willebrand factor (vWF)-directed antibody fragment. The report provides product ...

and are often treated with medical therapy or angioplasty and stenting. To identify whether age of 80 years or more increases morbidity, mortality and length of hospital stay after CEA.

HealthDay News — For patients with acute coronary syndrome (ACS) undergoing drug-eluting stent (DES) implantation, de-escalating dual antiplatelet therapy (DAPT) to P2Y12 inhibitor monotherapy is ...

The platform focuses on detecting coronary microvascular disease, a condition that is hard to diagnose, particularly in women. Credit: Jo Panuwat D / Shutterstock. US-based AngioInsight is set to ...

which the company said includes revisions to help users achieve optimal device size selection and stent braid deployment to “reduce the risk of complications and patient harms” by lowering the ...

"Considering that almost all patients in the combined treatment group achieved testosterone recovery at 1 year, the results support that this short term (intermittent) combined approach is an optimal ...

After hours: March 21 at 7:55:30 PM EDT Loading Chart for BSX ...